Why Medtronic Stock Dropped Today
Medtronic shares are down today after the company announced mixed voting results from the U.S. FDA's Circulatory System Devices Panel on its Symplicity Spyral renal denervation system. Wall Street ...
Medtronic Q1 2024 Earnings Review: Management Placates The Market
Medtronic's Q1 2024 earnings show 6% annual growth in revenues and EPS, marking a third consecutive quarter of mid-single-digit growth. The company's use of AI-driven tools and services, as well as...
Medtronic shares fall after FDA advisors' lukewarm vote on blood-pressure treatment device
Medtronic PLC shares MDT, -0.05% were down 1.3% premarket on Thursday after advisors to the U.S. Food and Drug Administration had a mixed reaction to the company's investigational renal denervation...
US FDA panel votes against use of Medtronic's blood pressure treatment device
The U.S. Food and Drug Administration's independent experts on Wednesday narrowly voted against recommending the approval of Medtronic's blood pressure treatment device, saying risks tied to using ...
MDT or PODD: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Products stocks are likely familiar with Medtronic (MDT) and Insulet (PODD). But which of these two stocks offers value investors a better bang for their buck righ...
Medtronic (MDT) Q1 Earnings Beat Estimates, Margins Up (Revised)
Strength across businesses and geographies, driven by execution, innovation, and improved underlying fundamentals contributes to Medtronic (MDT) Q1 revenues.
Medtronic to participate in upcoming investor conferences
DUBLIN , Aug. 22, 2023 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today confirmed its participation in the following upcoming investor conferences: 2023 Wel...
Why Medtronic Stock Was a Winner Today
The medical device maker unveiled its results for the first quarter of fiscal 2024. It topped analyst estimates for both revenue and adjusted profitability.
Medtronic CEO: Our biggest driver is our diabetes business where we doubled growth
Geoffrey Martha, Medtronic Chairman and CEO, joins 'Squawk on the Street' to discuss the company's quarterly earnings results, the key drivers in the quarter and Medtronic's business in China.
Medtronic (MDT) Q1 Earnings Beat Estimates, Margins Down
Strength across businesses and geographies, driven by execution, innovation and improved underlying fundamentals, contributes to Medtronic's (MDT) Q1 revenues.
Medtronic (MDT) Reports Q1 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Medtronic (MDT) give a sense of how the business performed in the quarter ended July 2023, it could be worth looking at how some of its key metrics compar...
Medtronic (MDT) Surpasses Q1 Earnings and Revenue Estimates
Medtronic (MDT) came out with quarterly earnings of $1.20 per share, beating the Zacks Consensus Estimate of $1.11 per share. This compares to earnings of $1.13 per share a year ago.
Will Medtronic (MDT) Beat Estimates Again in Its Next Earnings Report?
Medtronic (MDT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
US FDA staff raise no concerns about Otsuka, Medtronic blood pressure devices
The U.S. Food and Drug Administration (FDA) staff reviewers said on Friday they found no safety and effectiveness issues with devices made by Otsuka Holdings and rival Medtronic Plc for use in a bl...
What's in the Cards for Medtronic (MDT) in Q1 Earnings?
Strength across all businesses is likely to drive Medtronic's (MDT) first-quarter performance.
Related Companies